7 Products Boston Scientific is Betting on in 2014: Alair Bronchial Thermoplasty System

Posted in Cardiovascular by Jamie Hartford on February 4, 2014

Alair Bronchial Thermoplasty System

The first FDA-approved nondrug outpatient procedure to treat severe and persistent asthma, Alair saw 25% growth last year and is now offered at more than 350 worldwide treatment sites. Mahoney said reorder rates are improving and large commercial insurers are greenlighting it for more case-by-case approvals.

Introduction Premier 




[image courtesy of BOSTON SCIENTIFIC]

Printer-friendly version
No votes yet

Login to post comments